ArticleNPJ precision oncology2025

Case report: Successful use of MEK inhibitors as an adjuvant approach in the treatment of pediatric MAP4-RAF1 fusion-positive solid tumor.

Shen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.